Outcome of Board meeting held on May 30, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Coral Laboratories Ltd's Board approved audited standalone financial results for Q4 and FY ended March 31, 2026. Revenue from operations declined to ₹8,590 Lakhs from ₹11,501 Lakhs in the previous year (25.3% decline). Profit after tax fell to ₹1,638 Lakhs from ₹2,416 Lakhs (32.2% decline), though PAT remained positive. EBITDA margin compressed from approximately 26.8% to 24%. The Board recommended a final dividend of ₹2 per share (20% on face value of ₹10). The statutory auditor issued an unmodified opinion confirming clean financial reporting. New internal auditor (M/s S K Doshi & Associates) and cost auditor (M/s Aatish Dhatrak & Associates) were appointed for FY 2026-27.
The company experienced significant revenue and profit decline in FY 2025-26, though the dividend recommendation signals management confidence. The clean audit opinion and continued profitability provide some support despite the challenging year.